Viral Retinitis After Intravitreal Triamcinolone Injection in Patients With Predisposing Medical Comorbidities

American Journal of Ophthalmology

Volumn 149, Issue 3, 2010, Pages

  Shah, Ankur M ^a   Oster, Stephen F ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE; VALGANCICLOVIR;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINITIS; RISK FACTOR;

EID: 76749134801     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.10.019     Document Type: Article

References (36)

1. Wiegand T.W., and Young L.H. Cytomegalovirus retinitis. Int Ophthalmol Clin 46 (2006) 91-110
2. Kuo I.C., Kempen J.H., Dunn J.P., et al. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol 138 (2004) 338-346
3. Crippa F., Corey L., Chuang E.L., et al. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clin Infect Dis 32 (2001) 214-219
4. Benz M.S., Glaser J.S., and Davis J.L. Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids. Am J Ophthalmol 135 (2003) 551-553
5. Browning D.J. Acute retinal necrosis following epidural steroid injections. Am J Ophthalmol 136 (2003) 192-194
6. Goldstein D.A., and Pyatetsky D. Necrotizing herpetic retinopathies. Focal Points: Clinical Modules for Ophthalmologists 26 (2008) 1-16
7. Freeman W.R., Thomas E.L., Rao N.A., et al. Demonstration of herpes group virus in acute retinal necrosis syndrome. Am J Ophthalmol 102 (1986) 701-709
8. Saidel M.A., Berreen J., and Margolis T.P. Cytomegalovirus retinitis after intravitreal triamcinolone in an immunocompetent patient. Am J Ophthalmol 140 (2005) 1141-1143
9. Delyfer M.N., Rougier M.B., Hubschman J.P., et al. Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand 85 (2007) 681-683
10. Ufret-Vincenty R.L., Singh R.P., Lowder C.Y., and Kaiser P.K. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert™) implant. Am J Ophthalmol 143 (2007) 334-335
11. Aggermann T., Stolba U., Brunner S., and Binder S. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection. Ophthalmologica 220 (2006) 131-133
12. Toh T.Y., and Borthwick J.H. Acute retinal necrosis post intravitreal injection of triamcinolone acetonide (2006), Royal Australian and New Zealand College of Ophthalmologists 380-382
13. Park Y.S., and Byeon S.H. Cytomegalovirus retinitis after intravitreal triamcinolone injection in a patient with central retinal vein occlusion. Korean J Ophthalmol 22 (2008) 143-144
14. Sekiryu T., Tomohiro I., Kaneko H., and Saito M. Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient. Jpn J Ophthalmol 52 (2008) 414-416
15. Jonas J.B., Kreissig I., Sofker A., and Degenring R.F. Intravitreal injection of triamcinolone for the treatment of diffuse diabetic macular edema. Arch Ophthalmol 121 (2003) 57-61
16. Jonas J.B., Kreissig I., and Degenring R.F. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136 (2003) 384-386
17. Antcliff R.J., Spalton D.J., Stanford M.R., et al. Intravitreal triamcinolone for uveitis cystoid macular edema: an optical coherence tomography study. Ophthalmology 108 (2001) 765-772
18. Park C.H., Jaffe G.J., and Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136 (2003) 419-425
19. Smithen L.M., Ober M.D., Maranan L., and Spaide R.F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138 (2004) 740-743
20. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 115 (2008) 1447-1459
21. Jabs D.A., Van Natta M.L., and Kempen J.H. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 133 (2002) 48-61
22. Morrison V.L., Kozak I., LaBree L.D., et al. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema. Ophthalmology 114 (2007) 334-339
23. Dalessandro L., and Bottaro E. Reactivation of CMV retinitis after treatment with subtenon's corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis 34 (2002) 780-782
24. Song M.K., Schrier R.D., Smith I.L., Plummer D.J., and Freeman W.R. Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy. Retina 22 (2002) 262-267
25. Jacobson M.A., Zegans M., Pavan P.R., et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349 (1997) 1443-1445
26. Petit N., Zandotti C., Riss J.M., et al. Relapse of CMV retinitis in an AIDS patient with high CD4 counts. J Antimicrob Chemother 41 (1998) 666-667
27. Angus B.J., et al. HIV-associated CMV retinitis occurring in the setting of a high CD4 count: what about AIDS definitions?. Int J STD AIDS 5 (1994) 71-72
28. Frame R.D., Hutchins R.K., Skahan K.J., et al. Progression of cytomegaloviral retinitis in a patient responding to highly active antiretroviral therapy. Invest Ophthalmol Vis Sci 40 (1999) S873
29. Moshfeghi D.M., Kaiser P.K., Scott I.U., et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136 (2003) 791-796
30. Fintak D.R., Shah G.K., Blinder K.J., et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 28 (2008) 1395-1399
31. Morrison V.L., Koh H.J., Cheng L., et al. Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits. Retina 26 (2006) 339-344
32. Tammewar A.M., Cheng L., Kayikcioglu O.R., et al. Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections. Br J Ophthalmol 92 (2008) 810-813
33. Jonas J.B. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 137 (2004) 560-562
34. Jonas J.B. Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil. Br J Ophthalmol 86 (2002) 1450-1451
35. Kosobucki B.R., Freeman W.R., and Cheng L. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye. Br J Ophthalmol 90 (2006) 705-708
36. Beer P.M., Bakri S.J., Singh R.J., et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110 (2003) 681-686